ten consecutive patients ranging in age from seven to 34 years undergoing bone marrow transplantation from histocompatible siblings for treatment of hematologic malignancy were entered into a pilot study designed to test the safety of okt3 pretreatment of donor bone marrow for prevention of graft-vs.-host disease .
C0085379
okt3
C0018133
graft-vs